Journal rankings · indicator year 2022
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2022
Rheumatology journal rankings 2022
65 ranked journals · Subfield in Medicine
Rheumatology has 65 ranked journals in 2022. The median OJR fell 0.09 on 2021 to 0.87, below the world average of 1.00; Q1 starts at OJR 1.43. The top three are Arthritis & Rheumatology, Autoimmunity Reviews, and Osteoarthritis and Cartilage.
Ranks and citation indicators: 2022. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2019–2021, the window the 2022 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery1,001
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health310
- Cardiology and Cardiovascular Medicine296
- Oncology245
- Infectious Diseases243
- Epidemiology196
- Neurology176
- Radiology, Nuclear Medicine and Imaging165
- Physiology162
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health147
- Rheumatology65
Show all 42 subfields
- Orthopedics and Sports Medicine123
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology97
- Obstetrics and Gynecology88
- Hematology83
- Nephrology62
- Reproductive Medicine54
- Complementary and alternative medicine51
- Pharmacology51
- Emergency Medicine43
- Geriatrics and Gerontology38
- Rehabilitation36
- Otorhinolaryngology34
- Pathology and Forensic Medicine29
- Hepatology28
- Immunology and Allergy24
- Critical Care and Intensive Care Medicine23
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
65 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2021. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2019–2021, the window the 2022 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2019–2021 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2013 to 2022. | Compare |
|---|---|---|---|---|---|---|---|
1Arthritis & RheumatologyWiley · United States | 3.21Q1 | 9.40 1.15 down from 2021 | 879 | 53% | $5,190 | ||
2Autoimmunity ReviewsElsevier BV · Netherlands | 2.62Q1 | 11.43 3.07 down from 2021 | 500 | 42% | $4,730 | ||
3Osteoarthritis and CartilageElsevier BV · United Kingdom | 2.58Q1 | 6.00 0.84 down from 2021 | 562 | 100% | $3,700 | ||
4The Lancet RheumatologyElsevier BV · United Kingdom | 2.40Q1 | 11.12 3.80 down from 2021 | 388 | 53% | $7,280 | ||
5Best Practice & Research Clinical RheumatologyElsevier BV · Netherlands | 2.35Q1 | 5.95 0.20 down from 2021 | 162 | 46% | $4,180 | ||
6RMD OpenOABMJ · United Kingdom | 2.16Q1 | 6.78 0.35 up from 2021 | 397 | 100% | $2,391 | ||
7Current Rheumatology ReportsSpringer Science+Business Media · United States | 2.07Q1 | 6.32 0.73 up from 2021 | 240 | 48% | $4,490 | ||
8Arthritis Research & TherapyOABioMed Central · United Kingdom | 2.02Q1 | 5.34 0.80 down from 2021 | 869 | 100% | $3,690 | ||
9Nature Reviews RheumatologyNature Portfolio · United Kingdom | 2.01Q1 | 10.35 1.81 up from 2021 | 568 | 24% | — | ||
10Current Opinion in RheumatologyLippincott Williams & Wilkins · United States | 1.96Q1 | 5.62 0.01 up from 2021 | 237 | 29% | — | ||
11Arthritis Care & ResearchWiley · United States | 1.77Q1 | 4.41 0.53 down from 2021 | 796 | 62% | $4,640 | ||
12Therapeutic Advances in Musculoskeletal DiseaseOASAGE Publishing · United Kingdom | 1.65Q1 | 4.72 0.03 up from 2021 | 227 | 100% | $2,650 | ||
13Autoimmunity HighlightsOASpringer Science+Business Media · Italy | 1.64Q1 | 4.89 0.74 up from 2021 | 41 | — | $1,990 | ||
14Seminars in Arthritis and RheumatismElsevier BV · United States | 1.62Q1 | 5.30 0.29 down from 2021 | 490 | 54% | $4,370 | ||
15Rheumatology and TherapyOAAdis, Springer Healthcare · United Kingdom | 1.48Q1 | 4.26 0.09 down from 2021 | 265 | 100% | $7,400 | ||
16Expert Review of Clinical ImmunologyTaylor & Francis · United Kingdom | 1.44Q1 | 4.87 0.84 down from 2021 | 306 | 36% | — | ||
17Lara D. VeekenOxford University Press · United Kingdom | 1.43Q1 | 4.05 0.01 down from 2021 | 2,222 | 59% | $4,597 | ||
18Lupus Science & MedicineOABMJ · United Kingdom | 1.41Q2 | 3.98 0.99 down from 2021 | 165 | 100% | $2,391 | ||
19Rheumatic Disease Clinics of North AmericaElsevier BV · United States | 1.41Q2 | 2.96 0.09 up from 2021 | 152 | 16% | $3,500 | ||
20Journal of Translational AutoimmunityOAElsevier BV · Netherlands | 1.37Q2 | 4.86 0.08 up from 2021 | 129 | 100% | $3,180 | ||
21Rheumatology InternationalSpringer Science+Business Media · Germany | 1.36Q2 | 4.80 0.59 up from 2021 | 795 | 52% | $4,990 | ||
22European Cells and MaterialsOASwitzerland | 1.32Q2 | 3.27 1.61 down from 2021 | 154 | 100% | $1,000 | ||
23ACR Open RheumatologyOAWiley · United States | 1.22Q2 | 3.41 0.41 down from 2021 | 335 | 100% | $3,550 | ||
24Open Access Rheumatology Research and ReviewsOADove Medical Press · New Zealand | 1.12Q2 | 2.76 0.11 down from 2021 | 108 | 100% | $2,320 | ||
25Revista Brasileira de ReumatologiaOAElsevier BV · Brazil | 1.12Q2 | 2.90 0.80 down from 2021 | 181 | 100% | $2,490 | ||
26CartilageSAGE Publishing · United States | 1.10Q2 | 3.00 0.10 up from 2021 | 374 | 100% | $2,650 | ||
27Clinical RheumatologySpringer Science+Business Media · Belgium | 1.07Q2 | 3.56 0.18 down from 2021 | 1,510 | 41% | $4,890 | ||
28BMC RheumatologyOABioMed Central · United Kingdom | 1.07Q2 | 2.65 0.54 down from 2021 | 176 | 100% | $2,190 | ||
29Annals of the Rheumatic DiseasesBMJ · United Kingdom | 1.06Q2 | 6.37 3.03 up from 2021 | 4,116 | 97% | $4,870 | ||
30The Journal of RheumatologyThe Journal of Rheumatology Publishing Company Limited · Canada | 1.01Q2 | 2.44 0.95 down from 2021 | 919 | 68% | — | ||
31LupusSAGE Publishing · United Kingdom | 0.92Q2 | 2.68 0.12 up from 2021 | 738 | 21% | $4,150 | ||
32Connective Tissue ResearchTaylor & Francis · United Kingdom | 0.87Q2 | 2.41 0.53 down from 2021 | 170 | 31% | — | ||
33Rheumatology Advances in PracticeOAOxford University Press · United Kingdom | 0.87Q2 | 2.46 0.17 up from 2021 | 214 | 100% | $2,974 | ||
34Clinical Medicine Insights Arthritis and Musculoskeletal DisordersOASAGE Publishing · United Kingdom | 0.83Q3 | 3.33 0.44 up from 2021 | 47 | 100% | $4,150 | ||
35Modern RheumatologyOxford University Press · United States | 0.82Q3 | 2.26 0.39 down from 2021 | 468 | 39% | $3,208 | ||
36International Journal of Rheumatic DiseasesWiley · Australia | 0.80Q3 | 2.51 0.02 up from 2021 | 667 | 26% | $3,700 | ||
37Joint Bone SpineElsevier BV · France | 0.80Q3 | 2.61 0.18 up from 2021 | 464 | 48% | $3,020 | ||
38International Urogynecology JournalSpringer Science+Business Media · United Kingdom | 0.78Q3 | 2.04 0.11 up from 2021 | 1,035 | 42% | $3,790 | ||
39Osteoarthritis and Cartilage OpenOAElsevier BV · United Kingdom | 0.72Q3 | 1.97 0.14 down from 2021 | 159 | 100% | $1,610 | ||
40Reumatologia/RheumatologyOATermedia Publishing House · Poland | 0.66Q3 | 2.14 0.10 up from 2021 | 205 | 100% | — | ||
41Scandinavian Journal of RheumatologyTaylor & Francis · United Kingdom | 0.62Q3 | 1.53 0.42 down from 2021 | 305 | 45% | — | ||
42Musculoskeletal CareWiley · United Kingdom | 0.62Q3 | 1.81 0.05 down from 2021 | 215 | 60% | $3,240 | ||
43UrogynecologyLippincott Williams & Wilkins · United States | 0.61Q3 | 1.50 0.11 up from 2021 | 429 | 18% | — | ||
44ReumatismoOAPAGEPress (Italy) · Italy | 0.60Q3 | 1.68 0.26 up from 2021 | 101 | 100% | — | ||
45Current Rheumatology ReviewsBentham Science Publishers · Netherlands | 0.55Q3 | 1.63 0.18 up from 2021 | 103 | 5% | — | ||
46European Journal of RheumatologyOAAVES Yayincilik · Türkiye | 0.49Q3 | 1.51 0.56 down from 2021 | 171 | 100% | — | ||
47Mediterranean Journal of RheumatologyOAGreece | 0.43Q3 | 1.18 0.25 down from 2021 | 150 | 100% | — | ||
48Archives of RheumatologyOATürkiye | 0.42Q3 | 1.07 0.01 down from 2021 | 289 | 100% | — | ||
49JCR Journal of Clinical RheumatologyLippincott Williams & Wilkins · United States | 0.41Q3 | 1.30 0.39 up from 2021 | 787 | 29% | — | ||
50Modern Rheumatology Case ReportsOxford University Press · United Kingdom | 0.38Q4 | 1.26 0.54 up from 2021 | 214 | 17% | $1,071 |
Subfields of Medicine, with Rheumatology highlighted.
- Surgery1,001
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health310
- Cardiology and Cardiovascular Medicine296
- Oncology245
- Infectious Diseases243
- Epidemiology196
- Neurology176
- Radiology, Nuclear Medicine and Imaging165
- Physiology162
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health147
- Orthopedics and Sports Medicine123
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology97
- Obstetrics and Gynecology88
- Hematology83
- Rheumatology65
- Nephrology62
- Reproductive Medicine54
- Complementary and alternative medicine51
- Pharmacology51
- Emergency Medicine43
- Geriatrics and Gerontology38
- Rehabilitation36
- Otorhinolaryngology34
- Pathology and Forensic Medicine29
- Hepatology28
- Immunology and Allergy24
- Critical Care and Intensive Care Medicine23
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2022. Corpus-wide, 89.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
24 additional Rheumatology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2019–2021, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2022. Publication window: 2019–2021. How these summaries are calculated
- Ranked journals
- 65
- Window papers (baseline)
- 65,720 +14.7% from indicator year 2019
- Median OJR
- 0.869 -6.7% from indicator year 2019
- Rising journals (2025)
- 6
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2019–2021 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 20 | 24 | 25 | 27 | 30 | 32 | 37 | 38 | 38 | 39 | 43 | 49 | 53 | 56 | 59 | 58 | 58 | 65 | 65 | 67 | 69 | 67 | 65 | 67 | 67 | 70 | |
| Window papers (baseline) | 17,821 | 20,685 | 22,377 | 24,459 | 25,269 | 27,867 | 30,643 | 33,672 | 36,348 | 39,439 | 42,988 | 46,086 | 48,179 | 49,400 | 51,214 | 53,341 | 54,578 | 55,366 | 56,123 | 57,306 | 59,410 | 62,541 | 65,720 | 67,501 | 67,701 | 69,555 | |
| Median OJR | 0.91 | 0.782 | 0.862 | 0.81 | 0.884 | 1.05 | 0.855 | 0.803 | 0.92 | 0.891 | 0.7969 | 0.888 | 0.877 | 0.95 | 0.879 | 0.847 | 0.9574 | 0.889 | 0.873 | 0.93 | 0.99 | 0.9569 | 0.869 | 0.851 | 0.785 | 0.7970 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.